Search research articles
Contact Us
Filters
Showing results (121-130 of 213) with videos related to
Page
of 22
Sort By:
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2025
LAMP1 as a Target for PET Imaging in Adenocarcinoma Xenograft Models
Bahar Ataeinia, Arvin Haj-Mirzaian, Lital Ben-Naim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 13, 2015
Imaging of Secreted Extracellular Periostin, an Important Marker of Invasion in the Tumor Microenvironment in Esophageal Cancer
Pedram Heidari, Shadi A Esfahani, Nazife S Turker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 16, 2016
Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance
Eric Wehrenberg-Klee, N Selcan Turker, Pedram Heidari, et al.
Diagnostics (Basel, Switzerland)
|
December 11, 2025
Granzyme B PET Imaging Enables Detection of CAR T-Cell Therapy Response in a Human Melanoma Mouse Model
Priska Summer, Niklas Bulmer, Suma Prabhu, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
May 24, 2017
A phase one, single-dose, open-label, clinical safety and PET/MR imaging study of <sup>68</sup>Ga-DOTATOC in healthy volunteers
Shadi A Esfahani, Stephanie Salcedo, Pedram Heidari, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
November 24, 2025
Molecular tumor volume on PSMA PET/CT is an independent imaging biomarker associated with progression-free survival in patients with oligorecurrent prostate cancer
Monica Cheng, Umar Mahmood, Nathaniel D Mercaldo, et al.
Circulation
|
June 12, 2002
In vivo imaging of proteolytic activity in atherosclerosis
Jiqiu Chen, Ching-Hsuan Tung, Umar Mahmood, et al.
Radiology
|
July 24, 2008
Human breast cancer tumor models: molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy
Michael S Gee, Rabi Upadhyay, Henry Bergquist, et al.
Plos One
|
August 13, 2013
Genotype directed therapy in murine mismatch repair deficient tumors
Melanie H Kucherlapati, Shadi Esfahani, Peiman Habibollahi, et al.
Plos Medicine
|
April 18, 2008
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma
Kimberly A Kelly, Nabeel Bardeesy, Rajesh Anbazhagan, et al.
Page
of 22
Search research articles
Search
Showing results (121-130 of 213) with videos related to
Sort By:
Page
of 22
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2025
LAMP1 as a Target for PET Imaging in Adenocarcinoma Xenograft Models
Bahar Ataeinia, Arvin Haj-Mirzaian, Lital Ben-Naim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 13, 2015
Imaging of Secreted Extracellular Periostin, an Important Marker of Invasion in the Tumor Microenvironment in Esophageal Cancer
Pedram Heidari, Shadi A Esfahani, Nazife S Turker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 16, 2016
Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance
Eric Wehrenberg-Klee, N Selcan Turker, Pedram Heidari, et al.
Diagnostics (Basel, Switzerland)
|
December 11, 2025
Granzyme B PET Imaging Enables Detection of CAR T-Cell Therapy Response in a Human Melanoma Mouse Model
Priska Summer, Niklas Bulmer, Suma Prabhu, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
May 24, 2017
A phase one, single-dose, open-label, clinical safety and PET/MR imaging study of <sup>68</sup>Ga-DOTATOC in healthy volunteers
Shadi A Esfahani, Stephanie Salcedo, Pedram Heidari, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
November 24, 2025
Molecular tumor volume on PSMA PET/CT is an independent imaging biomarker associated with progression-free survival in patients with oligorecurrent prostate cancer
Monica Cheng, Umar Mahmood, Nathaniel D Mercaldo, et al.
Circulation
|
June 12, 2002
In vivo imaging of proteolytic activity in atherosclerosis
Jiqiu Chen, Ching-Hsuan Tung, Umar Mahmood, et al.
Radiology
|
July 24, 2008
Human breast cancer tumor models: molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy
Michael S Gee, Rabi Upadhyay, Henry Bergquist, et al.
Plos One
|
August 13, 2013
Genotype directed therapy in murine mismatch repair deficient tumors
Melanie H Kucherlapati, Shadi Esfahani, Peiman Habibollahi, et al.
Plos Medicine
|
April 18, 2008
Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma
Kimberly A Kelly, Nabeel Bardeesy, Rajesh Anbazhagan, et al.
Page
of 22